Biotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY
ZacksNovavax, Inc (NVAX) and Fulcrum Therapeutics, Inc (FULC) are in the spotlight following license agreements with pharma giant Sanofi.
Novavax, Inc (NVAX) and Fulcrum Therapeutics, Inc (FULC) are in the spotlight following license agreements with pharma giant Sanofi.